Search
- Dec 28, 2023
As Perlara approaches its 10 yr anniversary, Ethan Perlstein reflects on his entrepreneur's journey and vision for DTC biotech
Ethan Perlstein describes the past and present of his rare diseases-focused company Perlara
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A